Virus filtration using small pore virus filter in downstream processing of biotherapeutic products: The effect of operating pressure.

Buffer flush Depressurization High pressure Planova 20 N Virus filtration (VF) Virus leakage

Journal

Biologicals : journal of the International Association of Biological Standardization
ISSN: 1095-8320
Titre abrégé: Biologicals
Pays: England
ID NLM: 9004494

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 11 12 2022
revised: 18 09 2023
accepted: 01 10 2023
medline: 4 12 2023
pubmed: 15 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

Virus filtration is a robust and effective method to remove potential virus contaminants. Planova 20 N, a virus filter form Asahi Kasei Bioprocess, has been widely used in the manufacturing process of biotherapeutics. Previous studies have shown that parvovirus removal by Planova 20 N can be impacted by low operation pressure and depressurization. Therefore, it is critical to define an operating pressure range for robust virus removal. In this work, the effect of pressure combined with depressurization on virus removal by Planova 20 N was investigated. Our studies showed that effective virus removal can be achieved in the pressure range from 0.7 bar to 1.6 bar. The data also suggest that re-starting with higher pressure after depressurization is highly desirable for large-scale manufacture to mitigate virus leakage risk. In addition, skipping buffer flush post mainstream filtration minimizes the likelihood of depressurization.

Identifiants

pubmed: 37837714
pii: S1045-1056(23)00056-8
doi: 10.1016/j.biologicals.2023.101718
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101718

Informations de copyright

Copyright © 2023 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Auteurs

Na Liu (N)

Downstream Process Development (DSPD), WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, China. Electronic address: liu_na@wuxibiologics.com.

Tiandan Xu (T)

Downstream Process Development (DSPD), WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, China.

Articles similaires

Evolution shapes and conserves genomic signatures in viruses.

Martin Holmudden, Joel Gustafsson, Yann J K Bertrand et al.
1.00
Genome, Viral Evolution, Molecular Viruses Genomics Codon Usage

Molecular mimicry as a mechanism of viral immune evasion and autoimmunity.

Cole Maguire, Chumeng Wang, Akshara Ramasamy et al.
1.00
Molecular Mimicry Humans Autoimmunity Immune Evasion Herpesvirus 4, Human
1.00
Metagenomics Humans Public Health Software High-Throughput Nucleotide Sequencing

Microbial distribution in Mudbank regions off Alappuzha, South-West coast of India.

Jasna Vijayan, Parvathi Ammini, Angia Sriram Pradeep Ram et al.
1.00
India Environmental Monitoring Seawater Seasons Viruses

Classifications MeSH